Autopsy report · NCT01025882

Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer

“DSMC closed due to patient deaths”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 1 year 4 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Texas Southwestern Medical Center

Sponsor type

University, hospital or other

Conditions

Pancreatic Cancer

Interventions

gemcitabine hydrochloride; stereotactic body radiation therapy

Participants

5

Sites

1

Countries

United States

Trials that died the same way

• Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
  “DSMB closed due to futility.” (59% match in meaning)
• A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
  “Closed due to slow patient accrual.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.